Progression from at-risk state to clinical and severe systemic lupus erythematosus involves molecular dysregulations potentially reversible by biologics: implications for early diagnosis and treatment

Journal:
Annals of the Rheumatic Diseases
Published:
DOI:
10.1016/j.ard.2026.02.003
Affiliations:
30
Authors:
25
Go to article
Institutions Authors Share
University of Crete (UOC), Greece
6.333333
 0.25
Biomedical Research Foundation of the Academy of Athens (BRFAA), Greece
3.250000
 0.13
Biomedical Sciences Research Centre Alexander Fleming (BSRC Fleming), Greece
2.500000
 0.10
University of Pisa (UNIPI), Italy
2.000000
 0.08
Foundation for Research and Technology - Hellas (FORTH), Greece
1.500000
 0.06
University of Leeds, United Kingdom (UK)
1.500000
 0.06
University General Hospital Attikon, Greece
1.250000
 0.05
University Hospital of Erlangen, FAU, Germany
1.000000
 0.04
University of Coimbra (UC), Portugal
1.000000
 0.04
Hippokration Hospital of Thessaloniki, Greece
0.833333
 0.03
Aristotle University of Thessaloniki (AUTH), Greece
0.833333
 0.03
European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ERN ReCONNET), Italy
0.666667
 0.03
Azienda Socio Sanitaria Territoriale (ASST) degli Spedali Civili di Brescia, Italy
0.666667
 0.03
University of Brescia (UNIBS), Italy
0.666667
 0.03
The Newcastle Upon Tyne Hospitals NHS Foundation Trust (NUTH), United Kingdom (UK)
0.500000
 0.02
Karolinska University Hospital, Sweden
0.250000
 0.01
Center for Molecular Medicine (CMM), Sweden
0.250000
 0.01
Interested in Clinical Sciences?